INTERNATIONAL SOCIETY FOR THE STUDY OF EMERGING DRUGS CIC
WELLESLEY HOUSE DUKE OF WELLINGTON AVENUE, ROYAL ARSENAL, LONDON  SE18 6SS- Active
- Community Interest Company
- Company No. 12520628
- Last Updated: 01 Mar 2024
Company Profile
INTERNATIONAL SOCIETY FOR THE STUDY OF EMERGING DRUGS CIC was incorporated on Tuesday, March 17, 2020 as a Community Interest Company with registered address in LONDON. INTERNATIONAL SOCIETY FOR THE STUDY OF EMERGING DRUGS CIC has the status: Active and it's listed in the following category: Activities of other membership organizations n.e.c.. This Community Interest Company has been operating for 4 years 11 months and 8 days.
Name | INTERNATIONAL SOCIETY FOR THE STUDY OF EMERGING DRUGS CIC |
---|---|
Company number | 12520628 |
Company type | Community Interest Company |
Incorporation date | 17 Mar 2020 |
Status | Active |
Industry (SIC 2007) |
Address
Registered Address |
WELLESLEY HOUSE DUKE OF WELLINGTON AVENUE ROYAL ARSENAL LONDON SE18 6SS |
---|---|
Country Of Origin | UNITED KINGDOM |
Map based on PostCode
Ownership Information
Individuals and organizations with significant control over the business either by owning at least 25% shares or by virtue of significant influence over the business.
Name | Nature of Control |
---|---|
Dr Andres Ernesto Roman Urrestarazu Nationality: British |
Dates: Tuesday, March 17, 2020 - present
voting rights 25 to 50 percent
|
Ornella Corazza Nationality: Italian |
Dates: Tuesday, March 17, 2020 - present
voting rights 25 to 50 percent
|
Accounts and Confirmation
Type of accounts | TOTAL EXEMPTION FULL |
---|---|
End of financial Year | 31 March |
Next annual accounts due | 31 December 2024, (-56 days left) |
Latest accounts | 31 March 2023 |
Next confirmation statement due | 14 April 2021 |
Last confirmation statement dated | Not available |
Mortgages
No mortgages have been registered against INTERNATIONAL SOCIETY FOR THE STUDY OF EMERGING DRUGS CIC.
Previous Names
Name | Change Date |
---|---|
INTERNATIONAL SOCIETY FOR THE STUDY OF EMERGING DRUGS CIC | 17 Mar 2020 |